Clinical Report: Consensus Recommendations for Psoriasis Management in APAC

Background

Psoriasis affects approximately 43 million people globally and poses a significant health burden, particularly in the Asia-Pacific region. Despite advancements in treatment options, inconsistencies in care and gaps in severity classification and treatment escalation remain prevalent.

Data Highlights

No numerical or trial data was provided in the source material.

Key Findings

• 121 consensus statements were developed to guide psoriasis management in APAC.
• The approach emphasizes a combination of objective measures and quality-of-life impacts.
• High-impact sites should be given greater weight in treatment decisions.
• There is a need for timely and individualized use of systemic therapy.
• Current practices show a reliance on rigid stepwise escalation for treatment.
• Improved patient education and adherence support are necessary for better management.

Clinical Implications

Healthcare providers in the Asia-Pacific region should consider adopting the consensus recommendations to enhance psoriasis management. Emphasizing individualized treatment plans and addressing patient education can lead to improved adherence and outcomes.

Conclusion

The consensus recommendations highlight the necessity for a more consistent and patient-centered approach to psoriasis management in the Asia-Pacific region.

Related Resources & Content

1. Clinical Rheumatology, 2020 -- Guidelines from the International League of Associations for Rheumatology on Managing Psoriatic Arthritis in Low-Resource Environments
2. Clinical Rheumatology, 2023 -- Saudi Arabia's Expert Consensus on Psoriatic Arthritis Management
3. Frontiers in Neurology, 2026 -- Delphi consensus on the real-world application of the updated diagnostic and treatment guidelines for migraine in Asia Pacific
4. Dermatology and Therapy, 2026 -- Bridging the Gap in Chronic Prurigo Care: Evidence-Based Diagnostic and Therapeutic Recommendations from a Delphi Consensus Panel
5. EuroGuiDerm systemic-therapy guideline for psoriasis
6. NPF Issues Position Statement on Psoriasis Severity and Access to Care
7. Consensus on Routine Testing for Latent Tuberculosis Infection
8. Cochrane Living Network Meta-Analysis on Psoriasis Treatments
9. Risankizumab versus Deucravacitinib in Adults With Moderate Plaque Psoriasis: 16-Week Results from the Phase 4 IMMpactful Trial | Dermatology and Therapy | Springer Nature Link
10. Clinical Characteristics and Treatment Patterns of Psoriasis in Asia and Switzerland: Results of the Multicentre Global Healthcare Study on Psoriasis (GHSP) - Goh - 2026 - International Journal of Dermatology - Wiley Online Library
11. Call for public consultation – Draft Global Action Plan on Skin Diseases as a global health priority (GAP-SKIN)